设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2020 年第 7 期 第 15 卷

急性心肌梗死患者心型脂肪酸结合蛋白和高敏心肌肌钙蛋白T水平的变化及意义

The change and significance of heart-type fatty acid binding protein and high sensitive cardiac troponin T in patients with acute myocardial infarction

作者:邢宝宝1曹银芳1田丽丽2

英文作者:Xing Baobao1 Cao Yinfang1 Tian Lili2 

单位:1内蒙古自治区人民医院检验科,呼和浩特010010;2内蒙古自治区人民医院干部保健所四楼老年ICU,呼和浩特010010

英文单位:1Department of Laboratory Medicine Inner Mongolia People′s Hospital Hohhot 010010 China; 2ICU for the elderly on the fourth floor of Cadre Health Center Inner Mongolia People′s Hospital Hohhot 010010 China

关键词:急性心肌梗死;心型脂肪酸结合蛋白;高敏心肌肌钙蛋白;心电图

英文关键词:Acutemyocardialinfarction;Heart-typefattyacidbindingprotein;Highsensitivitycardiactroponin;Electrocardiogram

  • 摘要:
  • 目的探讨急性心肌梗死患者心型脂肪酸结合蛋白和高敏心肌肌钙蛋白T水平的变化及意义。方法选取2018112月内蒙古自治区人民医院急诊科收治的急性心肌梗死患者126例,根据心电图是否伴有ST段抬高分为ST段抬高组(98例)和非ST段抬高组(28例)。另纳入本院同期100例健康志愿者作为对照组。分别检测受试者血清心型脂肪酸结合蛋白、高敏心肌肌钙蛋白T水平,分析心电图、心型脂肪酸结合蛋白、高敏心肌肌钙蛋白T水平联合检测在急性心肌梗死临床诊断中的价值。结果ST段抬高组和非ST段抬高组患者心型脂肪酸结合蛋白水平明显高于对照组[(10.1±1.6)、(7.0±1.3)μg/L比(2.8±1.0)μg/L](t=39.16P<0.01t=18.04P<0.01),高敏心肌肌钙蛋白T水平明显高于对照组[(1.293±0.136)、(0.048±0.011)μg/L比(0.008±0.001)μg/L](t=94.49P<0.01t=36.20P<0.01),差异均有统计学意义。ST段抬高组心型脂肪酸结合蛋白、高敏心肌肌钙蛋白T水平显著高于非ST段抬高组(t=9.64P<0.01t=48.26P<0.01)。心型脂肪酸结合蛋白及高敏心肌肌钙蛋白T与心电图联合检测诊断急性心肌梗死的敏感度、准确率明显高于心电图单独检查(84.13%19.84%85.13%35.71%),差异均有统计学意义(均P<0.05)。结论急性心肌梗死患者心型脂肪酸结合蛋白及高敏心肌肌钙蛋白T水平明显升高,二者与心电图联合检测诊断急性心肌梗死有较高的敏感度和准确率。

  • ObjectiveTo investigate the change and significance of heart-type fatty acid binding protein and high sensitive cardiac troponin T in patients with acute myocardial infarction. Methods From January to December 2018, 126 patients with acute myocardial infarction admitted to the department of emergency Inner Mongolia Peoples Hospital were selected. The patients were divided into ST-segment elevation group(98 cases) and non ST-segment elevation group(28 cases) according to the results   of electrocardiogram. One hundred healthy volunteers were included as the control group during the same period. The level of serum heart-type fatty acid binding protein and high-sensitivity cardiac troponin T  of the three groups were detected respectively. The value of clinical diagnosis of combined detection of electrocardiogram, heart-type fatty acid binding protein and high-sensitivity cardiac troponin T in patients with acute myocardial infarction were analyzed. Results  The level of heart-type fatty acid binding protein in ST-segment elevation group and non ST-segment elevation group were significantly higher than that in the control group[(10.1±1.6, 7.0 ±1.3)μg/L vs 2.8±1.0)μg/L](t=39.16, P<0.01; t=18.04, P<0.01; the level of high-sensitivity cardiac troponin T were significantly higher than that in the control group[(1.293±0.136),(0.048±0.011)μg/L vs 0.008±0.001)μg/L](t=94.49, P<0.01; t=36.20, P<0.01. The levels of heart-type fatty acid binding protein and high sensitive cardiac troponin T in ST-segment elevation group were significantly higher than those in non ST-segment elevation groupt=9.64, P<0.01; t=48.26, P<0.01. The sensitivity and accuracy of combined detection of heart-type fatty acid binding protein, high-sensitivity cardiac troponin T and electrocardiogram in the diagnosis of acute myocardial infarction were significantly higher than those of electrocardiogram alone(84.13% vs 19.84%, 85.13% vs 35.71%, all P<0.05). Conclusions  The levels of heart-type fatty acid binding protein and high-sensitivity cardiac troponin T in patients with acute myocardial infarction are significantly high. The combined detection shows a high sensitivity and accuracy in the diagnosis of acute myocardial infarction. ='font-size:16px;font-family:"Calibri","sans-serif";mso-ascii-theme-font: minor-latin;mso-fareast-font-family:宋体;mso-fareast-theme-font:minor-fareast; mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language: ZH-CN;mso-bidi-language:AR-SA'>s Hospital, Hohhot 010010, China

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭